Praluent
Alirocumab · Regeneron Pharmaceuticals, Inc.
PRESCRIPTION ONLY (USA)Praluent ingredients
| Active ingredient | Strength |
|---|---|
| Alirocumab | 75 mg/mL, 150 mg/mL |
What Praluent is used for
Praluent is a specialist medicine (pcsk9 inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Praluent
- Generic name
- Alirocumab
- Made by
- Regeneron Pharmaceuticals, Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- PCSK9 Inhibitor
- FDA approval
- Biologic licence (BLA) BLA125559
- On the US market since
- 2015
Official information
- Praluent prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Alirocumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Praluent?
Praluent (Alirocumab) is a specialist medicine made by Regeneron Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Praluent?
Praluent contains Alirocumab (75 mg/mL, 150 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA